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Adult hematopoietic stem cells (HSCs) with serially
transplantable activity comprise two subtypes. One
shows a balanced output of mature lymphoid and
myeloid cells; the other appears selectively lymphoid
deficient. We now show that both of these HSC
subtypes are present in the fetal liver (at a 1:10 ratio)
with the rarer, lymphoid-deficient HSCs immediately
gaining an increased representation in the fetal bone
marrow, suggesting that the marrow niche plays
a key role in regulating their ensuing preferential
amplification. Clonal analysis of HSC expansion
posttransplant showed that both subtypes display
an extensive but variable self-renewal activity with
occasional interconversion. Clonal analysis of their
differentiation programs demonstrated functional
and molecular as well as quantitative HSC subtype-
specific differences in the lymphoid progenitors
they generate but an indistinguishable production
of multipotent and myeloid-restricted progenitors.
These findings establish a level of heterogeneity in
HSC differentiation and expansion control that may
have relevance to stem cell populations in other hier-
archically organized tissues.
INTRODUCTION
Hematopoietic stem cells (HSCs) are traditionally defined as
cells able to produce all types of blood cells in addition to
daughter HSCs with similarly unrestricted hematopoietic differ-
entiation potential. Such criteria arose from the initial demonstra-
tion of cells with both of these properties in experiments with
transplants of hematopoietic cells bearing unique genetic
markers (Dick et al., 1985; Jordan and Lemischka, 1990; Keller
and Snodgrass, 1990; Lemischka et al., 1986; Wu et al., 1968).
These experiments also revealed the heterogeneous differentia-
tion behavior of individually tracked HSCs, which was subse-
quently confirmed in limiting dilution transplantation assays
(Muller-Sieburg and Sieburg, 2006; Randall and Weissman,
1997; Smith et al., 1991; Spangrude et al., 1995; SzilvassyCet al., 2003; Zhong et al., 1996). Both stochastic and determin-
istic mechanisms have been invoked as explanations. More
recently, rigorous evidence of stably propagated heterogeneity
in the differentiation potential of individual adult HSCs has
been obtained from analysis of serially transplanted HSCs
(Challen et al., 2010; Dykstra et al., 2007; Kent et al., 2009;Morita
et al., 2010). These have shown definitively that durable regener-
ation of the HSC compartment is exclusively associated with
sustained myeloid differentiation activity, regardless of a contri-
bution to the circulating pool of lymphoid cells (Dykstra et al.,
2007).
HSCs with durable self-renewal activity but variable lympho-
poietic activity were first described as ‘‘myeloid-biased’’ and
‘‘balanced’’ based on measurements of the ratio of clonally
derived myeloid and lymphoid cells in the peripheral blood (PB)
of transplanted recipients (Muller-Sieburg et al., 2004). We
subsequently introduced the alternative, more neutral terms of
a- and b-HSCs to identify similar (albeit slightly differently
defined) HSC subtypes in order to avoid inferences about the
mechanisms responsible for their different output behaviors
before these were elucidated. In addition, we introduced
a more precise endpoint for their definition. This endpoint relies
on a comparison of separately determined clonal contributions
to the total PB lymphoid and myeloid compartments to circum-
vent host-specific variations in these values. Cell separation
studies have now shown that a-HSCs are preferentially enriched
in the most highly expressing CD150+ cell fraction but not suffi-
ciently to allow their discrimination frommany b-HSCs (Beerman
et al., 2010; Foudi et al., 2009; Kent et al., 2009; Morita et al.,
2010; Papathanasiou et al., 2009).
Previous studies have shown that HSCs can differ in a number
of other properties. These include developmental changes in
cycling status, rate of expansion posttransplant, and sensitivity
to steel factor (SF) (Bowie et al., 2007; Fleming et al., 1993;
Goodell et al., 1996; Kiel et al., 2005; Morrison et al., 1995; Paw-
liuk et al., 1996; Rebel et al., 1996). These findings prompted us
to investigate the HSC subtypes present before birth and how
their numbers might change thereafter. We also undertook an
analysis of the stages of differentiation that might be responsible
for the distinct lineage competencies that a- and b-HSCs
display. Through an assessment of the clones generated from
300 single-cell transplants, we now demonstrate the presence
of both a- and b-HSC subtypes throughout fetal and adult
life and in changing numbers relative to one another. Theseell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc. 273
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Figure 1. ESLAM Profiles for Cells from Different
Hematopoietic Tissues Analyzed at Different
Stages of Mouse Development
(A–H) FACS profiles of ESLAM cells. FL, fetal liver; FBM,
fetal bone marrow; adult BM, 8- to 12-week-old; old BM,
64- to 92-week-old.
(I) Frequency of cells with the ESLAM phenotype in each
tissue examined and the HSC purity of each ESLAM
population determined from the frequency of single
transplanted ESLAM cells that produced >1% of the
circulating WBCs present at 16 weeks posttransplant.
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are quite distinct from the previously reported fetal to adult
switch that affects other HSC properties. In addition, we identify
a number of unique kinetic, cellular, and molecular differences
that underpin their different behaviors.
RESULTS
HSCs from Multiple Sources Share a Common
Phenotype that Enables Their Consistent Isolation at
High Purities
Initial experiments indicated that hematopoietic tissues
throughout ontogeny and adulthood contain a rare population
of CD45+EPCR+CD48CD150+ (ESLAM) cells (Figures 1A–1I).
From 792 single-cell transplants of ESLAM cells isolated from
different primary hematopoietic organs, we found that >20%
from any single source tested and 31% (260/792) overall dis-
played HSC activity. This estimate is exclusive of any technical
losses or detection limitations as, for example, affect cycling
HSCs (in S/G2/M), which are prevalent prior to 4 weeks of age
(Bowie et al., 2007) and hence almost certainly cause the actual
purity of HSC-enriched preparations from these sources to be
underestimated approximately 2-fold.274 Cell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc.HSCs fromMultiple Sources Fit the Same
Spectrum of Differentiation Patterns
Characteristic of Adult Bone Marrow
We next investigated whether the same
discrete differentiation patterns previously
identified in studies of HSCs isolated from the
BM of adult mice by a different purification
strategy (Dykstra et al., 2007) would apply to
HSCs with an ESLAM phenotype isolated
from all of the hematopoietic sources examined
here (Figure 1). The differentiation pattern for
each clone was thus calculated as before as
the ratio of the 16-week clonal contribution to
the PB granulocytes plus monocytes (GMs)
compared to the PB B and T lymphocytes
(each identified by specific cell surface markers
as described in the Experimental Procedures).
This involved dividing the donor-derived GM
contribution to the total circulating GMs by
the donor-derived B+T contribution to the total
circulating B+T cells to obtain a value hereafter
referred to as the GM/(B+T) value. We thenused the k-means algorithm to analyze the distributions of the
260 GM/(B+T) values obtained. Figure 2A shows the cluster-
gram visualizing the GM/(B+T) values assigned to each cluster
for increasing numbers of clusters. The result for three clusters,
the number of clusters previously used to discriminate different
subtypes of adult HSCs by this approach (Dykstra et al., 2007),
is indicated by the black box in Figure 2A. Figure 2B shows
the distribution of the three cluster assignment of individual
GM/(B+T) values when these are displayed in a ternary plot. It
can be seen that the segregation of GM/(B+T) values obtained
for this larger collection of ESLAM HSCs isolated from different
tissue sources is similar to that previously described for a more
limited data set (Dykstra et al., 2007). Notably, a similar distribu-
tion was also recently reported for multiple adult HSC-derived
clones tracked in individual transplanted mice by a barcoding
strategy (Lu et al., 2011). Based on these similarities, we chose
to use the same definitions adopted previously to discriminate
lymphoid-deficient (a), balanced (b), and myeloid-deficient
(g+d) HSCs based on their 16-week GM/(B+T) values of >2.0,
0.25–2, and <0.25, respectively (Dykstra et al., 2007). Because
myeloid-deficient g+d-HSCs lack durable self-renewal activity,
we focused our analyses primarily on the a- and b-HSC
subtypes.
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Figure 2. Cluster Analysis of the Differentiation Programs Displayed
by Single Transplanted ESLAM Cells Obtained from All Stages of
Mouse Development
(A) Principal component analysis (PCA) values shown as a function of
increasing numbers of clusters fitted to clonal transplant GM/(B+T) values (n =
260 clones).
(B) Ternary plot showing the distribution of individual GM/(B+T) values
subdivided according to the three cluster analysis (k-means: three clusters
specified) with further segregation of the lymphoid-dominant (myeloid-
deficient) clones according to whether the contribution of the clone to the
total circulating GMs was more (g, shown in green) or less (d, shown in
yellow) than 1% at 16 weeks posttransplant. a-HSC-derived clones (shown
in blue) display high GM/(B+T) contribution ratios (>2.0), with b-HSC-derived
clones (shown in magenta) displaying more balanced GM/(B+T) contribution
ratios (0.25–2.0) as shown by the two black horizontal lines (taken from
a previous analysis of clones generated exclusively from adult BM (Dykstra
et al., 2007).
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CMarked but Incomplete Stability of a- and b-HSC
Differentiation Programs
To examine the stability of the differentiation programs of indi-
vidual a- and b-HSCs, we then examined the mature WBC
output patterns of a series of primary clones that were main-
tained for more prolonged periods (up to almost 2 years post-
transplant; Figure 3). This series included ten clones derived
from single a-HSCs and nine clones from single b-HSCs. The
results showed that the GM/(B+T) value for each clone remained
stable over the entire period it was followed, irrespective of the
starting HSC subtype or its tissue of origin for 17 of the 19 clones
monitored (Figure 4A and Figure S1 available online). These anal-
yses reveal the importance of separately relating donor-derived
lymphoid and myeloid differentiation outputs to the total output
of the corresponding lineage in each mouse at each time point
because of a generalized decrease in lymphocyte production
that occurs with aging (Figure S2; Cho et al., 2008). This shift
affected the lymphoid outputs of many of the clones as they
aged but did not alter the GM/(B+T) value, which normalizes
for host changes in circulating WBC numbers.
To investigate the stability of a- and b-differentiation program
maintenance at the HSC level, we then examined the clonalWBC
outputs of individual HSCs that had been regenerated in the
primary clones and transferred to secondary recipients (Figure 3).
Limiting dilution secondary transplants were first performed to
investigate the extent and variability of a- and b-HSC self-
renewal in different primary clones. In these experiments, we
calculated not only the total HSC content of the primary clones
by using the conventional endpoint to define secondary mice
as positive (>1% donor WBCs at 16 weeks posttransplant) but
also their content of a- plus b-HSCs only (donor GM/(B+T) value
of >0.25) to exclude HSCs with limited further self-renewal ability
(Dykstra et al., 2007). Of the 21 primary clones tested, 20
(7 a-HSCs and 13 b-HSCs) contained progeny HSCs at the
minimal dilution tested and in these the total HSC expansion
was extensive; i.e., >8-fold and up to >2,500-fold in the fraction
of BM cells tested (two femurs plus two tibiae plus the pelvis, left
panel of Figure 4B). Even using the more stringent endpoint to
identify daughter a- and b-HSCs, up to 500- to 1,800-fold expan-
sions were seen (right panel of Figure 4B). Interestingly, although
very few examples of secondary transplants at limiting dilution
were obtained, clear evidence of reactivation of lymphoid
programs by a-HSCs was documented (Figure S3).
To obtain a more definitive assessment of the fidelity of
program self-renewal, we performed single-cell transplants of
clonally regenerated ESLAM cells. Phenotypic analyses of the
cells from the primary mice revealed that donor-derived ESLAM
cells were present as a rare and variable population (from 64 to
980 per 5 3 107 BM cells; Table S1) and transplants of these
as single cells into secondary recipients (Figure 3) showed they
contained HSCs at a purity of 30%. From an analysis of the
WBC outputs of each of the positive secondary recipients, we
then determined the spectrum of HSC subtypes that had been
regenerated in eight primary clones (three from a-HSCs and
five from b-HSCs). Most of the HSCs produced from the primary
a-HSCs were also a-HSCs (8/13 = 61%). However, occasional
b and readily detectable g/d daughter HSCs were also evident
(8% and 31%of all daughter HSCs, respectively), indicating acti-
vation of a strong lymphopoietic potential in these progeny HSCsell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc. 275
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Figure 3. Schematic of the Overall Experimental Design
Cells with an ESLAM (CD45+EPCR+CD48CD150+) phenotype from the major sites of hematopoiesis in mice from before birth to old age were first isolated
and enumerated. Single ESLAM cells were then transplanted into sublethally irradiated CD45-congenicW41/W41 recipients. 8, 16, and 24 weeks posttransplant,
and for some recipients, at various time points thereafter, the circulatingWBCswere analyzed for their content of GMcells, B cells, and T cells that were donor and
recipient derived. From these values, the percent contributions of the donor clone to the total circulating mature lymphoid (B+T) andmyeloid (GM) compartments
were calculated. Subtype assignments of the original ESLAM HSCs transplanted were then made based on the ratio of their clonal contributions to the total
circulating GM and B+T lineages (GM/(B+T) value) determined for each primary clone 16 weeks posttransplant. The GM/(B+T) values were then used to calculate
the number of each HSC subtype in the original ESLAM population in the donor and, hence, to track the time course of the lifetime changes in total numbers of
different HSC subtypes that occur in mice. Measurements of the clonal content of additional stages of hematopoiesis defined phenotypically and/or functionally
(in secondary [2] transplants) were performed on BM cells harvested from primary recipients 6–26 months posttransplant and within a week of reassessing the
HSC clone subtype. Secondary transplants were performed by injecting varying numbers of unseparated cells or single (donor-type) ESLAM cells isolated from
the BM of the femurs, tibiae, and pelvis of individual primary (1) mice.
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derived clones, evidence of continued as well as conversion to
the alternate (a-HSC) differentiation program was also detected
(4% of daughter HSCs were also b-HSCs, but 8% were a-HSCs
along with 88% g/d-HSCs; Figures 4D and S3). Importantly,
many of the secondary clones that were classified as different
from the parental clone showed markedly different GM/(B+T)
values (right panel in Figures 4C and 4D). Taken together, these
findings provide definitive evidence of a variable but detectable
ability of both a-HSCs and b-HSCs to interconvert in addition
to propagating their own subtype.
a-HSCs Display Progressive and Lineage-Specific
Deficiencies in Their Differentiating Lymphoid Progeny
To investigate the basis of the different lineage outputs of a- and
b-HSCs, we first compared their outputs of various phenotypi-
cally defined intermediate progenitor compartments in primary
clones derived from each of these two HSC subtypes. The
results showed indistinguishable frequencies of all multipotent
and myeloid populations when a- and b-HSC-derived clones
were compared (Figure 5A). In contrast, the frequency of
common lymphoid progenitors (CLPs) in a-HSC-derived clones
was significantly lower (p < 0.05) than in b-HSC-derived clones
(Figure 5A). Indeed, in 3 of 28 a-HSC-derived clones analyzed,
no CLPs were detected (Figure 5A). As a result, the outputs of276 Cell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc.CLPs per multipotent (LSK) cell were significantly lower (p <
0.05) in the a-HSC-derived clones (Figure 5B). This reduced
frequency could not be attributed to the reported age-associ-
ated decline in CLP output (Miller and Allman, 2003), as it was
evident in both young and old a-HSC-derived clones but could
not be observed in b-HSC-derived clones even when these
were analyzed many months posttransplant.
Comparison of the donor contributions to the CLP compart-
ment in the BM and the B cell compartment in the PB showed
that these were significantly correlated in mice containing
b-HSC-derived clones (upper panel of Figure 5C). Similar results
were obtained for T cell outputs although the positive correlation
in mice containing b-HSC-derived clones was weaker (upper
panel of Figure S4). In contrast, therewas no correlation between
the clonal CLP numbers and the PB B cell or T cell contributions
for mice with a-HSC-derived clones (lower panels of Figures 5C
and S4).
These findings suggested that the CLPs produced in a-HSC-
derived clones might be qualitatively as well as quantitatively
deficient. To investigate this possibility, we examined the
frequency of regenerated CLPs that could produce B lineage
cells in vitro when cocultured with OP9 cells in the presence of
added interleukin-7 (IL-7) and Flt3-ligand (Nakano et al., 1994).
The results of these assays revealed a marked difference
between a- and b-HSC-derived CLPs independent of their
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Figure 4. Clonal Stability of HSC Differentiation
and Self-Renewal Behavior
(A) Stability beyond 16 weeks of the relative contributions
of a- or b-HSCs to the total circulating compartments of
mature GM, B, and T cells. The y axis on the left side of
each panel depicts the GM/(B+T) value (circle) calculated
for each time point when an assessment of the donor and
host contributions to these compartments was made. The
dotted lines indicate the threshold GM/(B+T) values for
a-HSCs (= 2.0) and b-HSCs (= 0.25). The y axis on the right
side of each panel shows the matching proportion of all
WBCs that were GM cells (donor + host; triangle), as this
value changes independently with aging. Representative
examples of data for mice reconstituted with a b-HSC (red,
left) and an a-HSC (blue, right) are shown. See also Figures
S1 and S2.
(B) Expansion of HSCs in clones produced in primary (1)
recipients of single a- (blue) or b-HSC (red) transplants.
From each clonally repopulated primary mouse, BM cells
from both femurs, both tibiae, and the pelvis were pooled
and aliquots injected directly into secondary (2) recipi-
ents. For the data in the left panel, secondary mice were
scored as positive if >1% of their circulating WBCs at
16 weeks posttransplant were of the same genotype as
the original ESLAM cell from which the primary clone had
been generated. From the frequencies derived from
these data, we calculated the total number of clonally
amplified HSCs present in the tissues analyzed and
hence the fold-expansion from the original HSC injected
into the primary mice. Each point (open circle) shows the
result for a separately analyzed primary clone. The right
panel shows similarly calculated results (closed circle)
from the same experiments with a more stringent defi-
nition of a positive secondary mouse (i.e., a donor-
derived GM/(B+T) value of >0.25) in order to estimate
exclusively the number of daughter HSCs likely to
possess continuing self-renewal potential (Dykstra et al.,
2007). The result for the one primary clone where no
positive secondary mice were obtained is indicated by
a downward arrow positioned at the detectable threshold
in that experiment. In the many cases where all
secondary mice were positive, the expansion value is
indicated by an upward arrow positioned at the minimum
value that could have given that result. Error bars show
the 95% CI. See also Figure S3.
(C and D) The numbers of HSC subtypes generated in primary (1) recipients of single a-HSCs (C, n = 3) and b-HSCs (D, n = 5) assessed by performing secondary
transplants with single ESLAM cells isolated from regenerated primary clones. Values shown in the left panels were pooled from data for primary clones derived
from the same original HSC subtype. The right panels show the GM/(B+T) values for the parental HSC (1) and derived daughter HSCs (2) for the one of three
a-HSCs found to generate b-HSC progeny in these secondary ESLAM transplants and the two of five b-HSCs similarly found to generate a-HSCs. Corre-
sponding GM/(B+T) values for the HSCs obtained from the other primary clones analyzed in this way are shown in Figure S3 (see also Table S1).
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of the clone, which ranged from 18 to 130 weeks; Table S2). All
b-HSCs produced functional CLPs at an average frequency of
7.8%±1.2% (Figure 5D). In contrast, many of the a-HSC-derived
clones, which were of a matching physiological age range,
produced no functional CLPs (in 16 clones analyzed, no CLPs
were detected in 3; 9 contained no functional CLPs; and in 4
productive CLPswere present at a normal frequency; Figure 5D).
We next asked whether these functional differences in the
CLPs produced by a- and b-HSCs might be associated with
differences in the expression of genes implicated in the regula-
tion of lymphoid cell differentiation (Northrup and Allman,
2008). From quantitative PCR analyses of transcripts from
10 genes, we found Pax5, Il7r, E2A (Tcf3), and Ikaros transcriptsCto be significantly decreased in CLPs generated from a- as
compared to b-HSCs (upper panel of Figure 5E). Some of these
differences are similar to those reported for CLPs isolated from
young and old mice (Lescale et al., 2010) and were partially
confirmed here (lower panel of Figure 5E). However, we did not
find that the regenerated CLPs from age-matched clones
showed any differences between each other (data not shown).
This indicates that the differences in gene expression of CLPs
from a- and b-HSC-derived clones are not attributable to differ-
ences in the ages of the clones from which they were isolated.
Rather, our findings suggest that the differences previously
associated with CLPs from young and old mice may be more
a reflection of their origins from different HSC subtypes than an
intrinsic aging process per se.ell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc. 277
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Figure 5. Comparison of the Output of Interme-
diate Stages of Myeloid and Lymphoid Differentia-
tion in Clones Produced by Single a- or b-HSCs
(A) Comparison of the numbers of donor-derived LSKs,
CMPs, GMPs, MEPs, CD41+CD61+ (megakaryocytes),
Ter119+CD71+ (erythroid progenitors), and CLPs present
in 5 3 107 BM cells from mice repopulated with a single
HSC. Significant differences (p < 0.0001) between
geometric means ± SEM are indicated.
(B) The output (mean ± SEM) of donor-derived CLPs
per donor LSK (p < 0.0001) in mice repopulated with a
single HSC.
(C) Pearson correlation analysis of the donor contribution
to the total circulating pool of B cells and the proportion of
BMCLPs that are donor derived for mice repopulated with
a single b-HSC (upper panel, n = 20) or a single a-HSC
(lower panel, n = 35). See also Figure S4.
(D) The frequency of B cell-producing CLPs was deter-
mined by limiting dilution analysis of CD19+ (B cell)
production after 9 to 12 days in OP9 cultures seeded with
variable numbers of test CLPs. Light blue triangles indicate
CLPs that showed no B cell producing activity. Black
triangles indicate clones where no CLPs were detected
(see also Table S2).
(E) Differences in expression of genes involved in B cell
andmyeloid differentiation in donor-derived CLPs isolated
from the BM of primary recipients of single b- and a-HSCs
(upper panel) and in CLPs derived from young and old
mice (lower panel). Quantitative real-time PCR analysis of
transcript levels was performed on extracts of 150 to 3,000
purified CLPs, isolated from primary recipients and
analyzed in replicate. All values have been normalized
relative to Gapdh transcript levels and are shown as the
mean ± SEM of values from ten a-HSC-derived CLPs
(seven samples consisting of the CLPs from five individual
clones and two pools of CLPs from five clones each) and
six clones of b-HSC-derived CLPs. Significant differences
(p < 0.05) are indicated.
Cell Stem Cell
Unique Properties of Lymphoid-Deficient HSCsTissue Site-Specific Changes in the Prevalence and
Number of HSC Subtypes during Development and
Aging
We next sought to investigate how each HSC subtype com-
partment changes throughout development and aging via
ESLAM single-cell transplants to define the distributions and
estimate the number of each subtype in the tissue analyzed.
The results are shown in Figures 6A and 6B. In the E14.5 fetal
liver (FL), 95% (41/43) of the HSCs detected were classified as
either b- or g/d-HSCs; however, two were clearly a-HSCs. In
mice transplanted with ten ESLAM cells each, we also found
two of five positive mice to contain donor-derived WBC out-
puts indicative of an a-HSC origin (GM/(B+T) values = 3 and
16). On the other hand, single-cell transplants of E14.5 FL
HSCs isolated with a different strategy (LinSca1+Mac1+
CD150+CD48 cells) confirmed the dominance of lymphoid-
competent HSCs at this stage of development (five b-HSCs
and two d-HSCs, data not shown) noted previously (Dykstra
et al., 2007). Thus, b-HSCs are clearly predominant in the
E14.5 FL, but a minor but detectable population of a-HSCs
(5%–10% of all HSCs) is also present.278 Cell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc.Four days later in development, the distribution of HSC
subtypes in the FL ESLAM cells is unchangedwith the a-subtype
again detectable but rare among all HSC subtypes (1/23 = 4%;
Figures 6A and 6C). At the same time, the total number of ESLAM
cells in the nascent fetal bone marrow (FBM) is much lower
(Table S3), but a-HSCs are more highly represented (4/20 =
17% of all HSC subtypes, and 31% of the a- and b-subtypes
only; Figures 6A and 6C). Thereafter, we found the ratio of
a-HSCs to b-HSCs in the BM (and spleen assessed at 3 weeks
after birth) remained relatively stable until much later in adult-
hood. By 9–10 months of age, the proportion of a-HSCs had
increased to become 45% of all HSC subtypes and 67% of the
a- and b-HSCs only (Figures 6A and 6B), and generally remained
high thereafter (Figures 6B), as previously reported (Beerman
et al., 2010; Cho et al., 2008; Dykstra et al., 2011). However,
greater variability between individual older mice was also noted,
as exemplified by the reduced proportion of a-HSCs obtained
from the two oldest mice used as donors (two 92-week-old
littermates).
To compare the physiologically determined changes in abso-
lute numbers of a- and b-HSCs that occur throughout the lifetime
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Figure 6. ESLAM HSCs Show Subtype-Specific
Differences in Their Prevalence and Population
Kinetics throughout Development and Aging
(A) Prevalence and purities of HSC subtypes in the ESLAM
population present in hematopoietic tissues at different
times in the life history of the mouse as determined from
analyses of recipients of single ESLAM cell transplants.
(B and C) Distributions of GM/(B+T) values for all HSCs
detected in hematopoietic tissues of mice analyzed at
different times throughout their development and aging
(n = 260). GM/(B+T) valueswere calculated as described in
the text and are plotted as a function of the age of the
donor from which the original ESLAM HSC transplanted
was obtained. The solid and dotted horizontal lines indi-
cate GM/(B+T) values of 2 and 0.25 that distinguish clones
derived from a- (>2), b- (0.25–2), or g/d- (<0.25) HSCs (see
Figure 2). Data for E18.5 FL (triangles) and BM (circles) are
shown separately (C). All other data are from BM (circles)
or spleen (diamonds) cells obtained from donor mice of the
ages indicated. Young adult BM data include 35 similarly
generated and analyzed clones published previously (Kent
et al., 2009).
(D) Subtype-specific changes in numbers of a-HSCs (top)
and b-HSCs (bottom) in the ESLAM population during
ontogeny and aging. These values were calculated from
total ESLAM cell numbers (= percent of ESLAM cells
multiplied by the total cellularity of each tissue analyzed)
and the frequency of a- and b-HSCs measured in each of
these ESLAM populations. The numbers shown also
incorporated the following assumptions: (1) at E14.5, all of
the HSCs are found in the FL; (2) at E18.5, all of the HSC
are found in the FL and BM (separate measurement of the
E18.5 spleen revealed no HSCs); (3) at 3 and 4 week after
birth, all HSCs are found in the BM and spleen (separate
measurement of the liver at that time failed to detect
ESLAM cells); (4) after 8–10 weeks of age, all HSCs are
found in the BM; (5) between E18.5 and 2 years of age, two
femurs, two tibiae, and the entire pelvis represent half of
the total BM of a mouse independent of its age (Boggs,
1984; Colvin et al., 2004); and (6) between E14.5 and
3 weeks after birth inclusive, all HSC assays detect only
half of those present because they are all in cycle and
those in S/G2/M (50%) do not engraft (Bowie et al.,
2006). See also Table S3.
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tissues at the different time points when these were assessed.
This involved multiplying each HSC frequency value determined
from single ESLAM transplants (Figure 1I) by the total number of
ESLAM cells in each tissue. The latter values, in turn, were deter-
mined bymultiplying the frequency of ESLAM cells in each tissue
(Figure 1I) by the total cellularity of that tissue (see also Figure 3).
For HSCs isolated from donors that were less than 4 weeks old,
we also multiplied their measured frequencies by 2 to compen-
sate for the S/G2/M fraction that is not detectable in transplanta-
tion assays (Bowie et al., 2006). Because we did not detect any
a- or b-HSCs in the E18.5 fetal spleen (only 4 of 20 E18.5 ESLAM
spleen cells were HSCs and all were of the d-subtype), the total
values did not include a contribution from this source. The
changing numbers over time of a- and b-HSCs per mouse calcu-
lated in this way are shown schematically in Figure 6D (with the
numbers shown in Table S3). Because the FL constitutes the
major reservoir of all HSCs between E14.5 and E18.5, both
a- and b-HSC populations can be seen to expand overall aboutC2-fold during this interval, retaining their markedly different
absolute levels (Figure 6A and Table S3). Interestingly, the
markedly changed ratio of a- to b-HSCs seen in the E18.5
FBM as compared to the E18.5 FL (approximately 1:2 as
compared to approximately 1:10, respectively) appears to
remain constant in the BM right into adulthood, by which time
the BM (and to a lesser extent the spleen) has assumed domi-
nance as the primary site of hematopoiesis and HSC localization
(Figure 6A). When the total number of HSCs at different stages of
development is calculated, a preferential expansion of a-HSCs
between E18.5 and 4 weeks after birth becomes evident (Fig-
ure 6D and Table S3). Interestingly, these calculations show no
indication of a net expansion in total HSC numbers per mouse
between E18.5 and 3 to 4 weeks after birth (720 versus 730–
800 per mouse), in spite of earlier evidence that most HSCs
are proliferating throughout this period (Bowie et al., 2006). A
further preferential expansion of a-HSCs in the BM in aging
mice is also seen as reported previously (Beerman et al., 2010;
Cho et al., 2008).ell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc. 279
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Adult HSC Subtypes Are Detectable in Fetal and
Neonatal Life
The observation of heterogeneity in HSC behavior is as old as
their identification and the mechanisms involved continue to
intrigue stem cell biologists. Recent support for intrinsically
established stable mechanisms underlying differences in the
differentiation potentialities displayed by individual HSCs has
been enabled by the development of purification methods that
have made single-cell transplants practical on a large scale.
Analyses of their clonally amplified progeny in serial transplant
experiments have suggested the stable self-propagation of
distinct differentiation programs characteristic of individual
HSCs (Dykstra et al., 2007; Muller-Sieburg et al., 2004). Another
source of heterogeneity in HSC behavior is reflected in the self-
renewal probability they display and their proliferation control
that appears to be developmentally regulated. How these vari-
able behaviors are determined and maintained and the extent
to which the HSCs that display them may be interrelated has
not been previously addressed.
Here we document the presence of an ESLAM population that
contains HSCs at high purity in hematopoietic tissues obtained
throughout the lifetime of a mouse from E14.5 to almost 2 years
of age. These HSCs display the same spectrum of differentiation
patterns reported for HSCs isolated from adult BM by a different
set of phenotypic markers (Dykstra et al., 2007). Our develop-
mental survey demonstrates an early origin and perpetuation
throughout life of two subtypes of HSCs that share extensive
self-renewal potential but display differing abilities to produce
lymphoid progeny. We have designated those with a robust
long-term myeloid potential but a poor ability to produce B and
T cells as a-HSCs. The second subtype, which makes long-
term and significant contributions to both the myeloid and
lymphoid lineages, we have called b-HSCs. These findings rein-
force a previously reported association of persistent myeloid
potential with durable HSC self-renewal activity for HSCs from
adult BM (Kent et al., 2009; Morrison and Weissman, 1994)
and demonstrate the fallacy in assuming that any HSC with
durable self-maintenance potential must also display both mye-
lopoietic and lymphopoietic activity within 4–6 months. Quantifi-
cation of the extent of the self-renewal activity of these two HSC
subtypes that are distinguished by their different lymphopoietic
abilities showed that more than 90% have expanded their
numbers >20-fold, and evidence of more than 2,500-fold expan-
sions during primary clone formation occur. Moreover, these
numbers are probably considerable underestimates because
they are based on estimates of a fraction of the BM in a mouse
that probably represents 25% to 50% of the total compartment
(Boggs, 1984; Colvin et al., 2004). This high self-renewal activity
provides encouragement that eventually it will be possible to
elicit and exploit this capability in vitro but also indicates that
very high self-renewal does not require a transformation event.
a- and b-HSC Differentiation Programs Show Extensive
but Not Rigid Stability
Long-termmonitoring of individual clones showed that their rela-
tive contributions to the total mature myeloid and lymphoid
WBCs remained quite stable over many months regardless of280 Cell Stem Cell 10, 273–283, March 2, 2012 ª2012 Elsevier Inc.their individual behaviors or developmental origin and in spite
of a common age-related shift toward a reduced overall produc-
tion of mature lymphoid cells. To examine the extent to which
this reflected a parallel stability in the daughter HSCs also being
generated in each clone, the patterns of WBC production in
secondary recipients of single HSCs from primary clones were
analyzed. The results showed that both a- and b-HSCs produce
many daughter HSCs with the parental differentiation program
but they also produce each other as well as g- and/or d-HSCs
at detectable frequencies. These findings formally demonstrate
that both a- and b-HSCs programs can interconvert in addition
to being strongly self-perpetuating.
Differences in the Lymphopoietic Potential of a- and
b-HSCs Are Explained by a Variable Ability to Execute
the Lymphoid Differentiation Program
Analysis of intermediate as well as mature stages of differentia-
tion in clones derived from both a- and b-HSC subtypes revealed
their clonal outputs of multipotent progenitors (LSK cells) and
myeloid-restricted progenitors (CMPs, GMPs, MEPs, erythroid
progenitors, and megakaryocytes) to be equivalent. In contrast,
the outputs of a-HSC-derivedCLPs, the functionality of theCLPs
they produced, and their gene expression profiles were all defi-
cient relative to those produced by b-HSCs. These findings do
not support a model of altered commitment to the myeloid
versus the lymphoid lineages as the mechanistic basis for the
differences in differentiation behavior that distinguish a- and
b-HSCs. Rather, they favor a mechanism that is propagated at
the HSC level but controls the efficiency of producing lymphoid
cells at multiple stages of their differentiation downstream of
events that affect fate choices between myeloid and lymphoid
lineages. In this regard, it is interesting to note that Muller-
Sieburg et al. (2004) reported a decreased IL-7 responsiveness
of lymphoid-deficient HSC progeny. Here we found that a- and
b-HSC-derived CLPs express similar cell surface levels of the
IL-7 receptor (data not shown). Taken together, these findings
suggest that differences in IL-7 responsiveness do not fully
explain the deficient lymphoid outputs of a-HSCs.
a- and b-HSC Compartments Begin Expanding at
Different Rates prior to the Fetal to Adult Switch
between 3 and 4 Weeks after Birth
Assessment of the relative and absolute changes in a- and
b-HSC numbers throughout development, adulthood, and aging
revealed unexpected changes in these parameters. In the mid-
gestation (E14.5) FL, i.e., 3–4 days after the first HSCs appear
(Dzierzak, 2005), b-HSCs are the dominant self-renewing HSC
subtype representing >90% of that population. Nevertheless,
coexisting a-HSCs are already present. Thus, b-HSCs are either
more likely to arise from their embryonic precursors or they have
a tremendous growth advantage over the coemerging a-HSCs in
the very earliest stages of HSC expansion. Such a growth advan-
tage of b-HSCswould, however, not fit with their equivalent rates
of expansion seen during the next 4 days when the numbers of
both are still rapidly increasing. Interestingly, this stability in the
ratio of a- to b-HSC numbers in the FL stands in marked contrast
to the results obtained for the same subtypes found in the BM. At
E18.5, the ratio of a- to b-HSCs in the BM is already at the same
(3-fold higher) level characteristic of adult BM. However, in the
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Figure 7. Model of the Different Rates of Expan-
sion throughout Life and Unique Patterns of Differ-
entiation of HSCs with Durable Self-Renewal
Ability
(A) Shown is a schematic representation of the different
kinetics of the compartments of lymphoid-deficient HSCs
(a-HSCs, left) and lympho-myeloid-balanced HSCs
(b-HSCs, right) throughout ontogeny and aging (y axis is an
arithmetic scale). b-HSCs are 103more prevalent in the FL
with a-HSCs becoming progressively dominant in the
postnatal and adult BM. Grey arrows indicate that both
a-HSCs and b-HSCs can interconvert as well as propa-
gate their same differentiation patterns during their self-
renewal divisions.
(B) Equal contribution of a- and b-HSCs to all of the
myeloid lineages and the continuous erosion of their lym-
phopoietic potential that characterizes multiple steps in
the development of mature lymphoid cells. These findings
are most consistent with a mechanism that operates at the
HSC level to influence the regulation of lymphopoiesis
rather than to regulate the choice between a myeloid
versus a lymphoid fate.
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the HSCs present. Thus, the BM HSC numbers do not influence
the overall a- and b-HSC compartment size estimates at this
time point. However, the stability of the increased representation
of a- versus b-HSCs in the BM as soon as the BM is colonized by
HSCs does suggest a potential role of the BMmicroenvironment
in mediating this difference. Further experiments will be of
interest to discern the mechanism(s) involved. Nevertheless, it
seems unlikely that they will be related to the mechanisms that
affect the cycling status and self-renewal activity of HSCs that
are altered rapidly and coordinately between 3 and 4 weeks after
birth (Bowie et al., 2006).
Eventually (after 1–2 years), we find that a-HSCs frequently
become the dominant HSC subtype. The observation of dom-
inant a-HSCs in old mice confirms similar recent reports of an
alteration in the composition of the HSC compartment during
aging (Beerman et al., 2010; Cho et al., 2008; Dykstra et al.,
2011) and is relevant to the question of the mechanisms
responsible for the well-documented age-associated decline
in lymphopoiesis (Labrie et al., 2004; Miller and Allman,
2003, 2005). Originally, this decline in the output of mature
lymphoid cells was ascribed to concomitantly acquired defi-
ciencies in the tissue structures (e.g., like the thymic epithe-
lium) required to support the continued production and
differentiation of lymphocyte precursors. However, subse-
quent studies of lymphopoietic cells from unperturbed mice
(Lescale et al., 2010) or mice reconstituted with bulk BM
cells (Rossi et al., 2005) have demonstrated an age-relatedCell Stem Cell 10,accrual of intrinsically determined deficiencies
in their numbers or functionality.
Taken together, the present findings support
an interesting model of HSC expansion and
maintenance throughout the lifetime of the
mouse (Figure 7). In this model, durable HSC
self-renewal potential is linked to predeter-
mined differentiation repertoires that ensurea stable myeloid differentiation potential but tolerate a variable
lymphopoietic potential, both of which originate within HSC
populations that appear in the early fetus. Despite their strongly
differential representation at that time, they appear to expand in
parallel until hematopoiesis begins to shift to the BM where the
lymphoid-deficient HSCs continuously gain ascendancy prob-
ably through successive self-renewal divisions, although the
generation of a-HSCs from b-HSCs could also be a contributing
mechanism.
The described evidence of heterogeneity in HSC differentia-
tion programs underscores the need for more complex models
of how these processes are regulated and reinforces the need
for single-cell and clonal analyses to reconstruct mechanisms
of tissue development, homeostasis, regeneration, and transfor-
mation. Given the accessibility of HSCs to such investigations,
the lessons to be learned may also benefit understanding other
cell renewal systems where evidence of stem cell heterogeneity
has been reported (Takeda et al., 2011; Tian et al., 2011; Van
Keymeulen et al., 2011; Yan et al., 2012).
EXPERIMENTAL PROCEDURES
Mice
All experiments used C57BL/6J (B6)-Ly5.1 or -Ly5.2 mice as donors and
congenic sublethally irradiated B6-W41/W41-Ly5.1 and -Ly5.2 (W41-5.1 and
W41-5.2) mice as recipients according to institutionally approved procedures.
Transplantations and analyses of transplanted mice were performed as previ-
ously described (Kent et al., 2007). The HSC subtype origin of each clone was
first determined 16 weeks posttransplant and for secondary transplants was273–283, March 2, 2012 ª2012 Elsevier Inc. 281
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are provided in the Supplemental Experimental Procedures.
Flow Cytometric Analysis and Cell Sorting
Single-cell suspensions of FL, FBM, spleen, and adult BM cells were stained
with antibodies and viable ESLAM and CLPs isolated with a double sort
strategy on a FACSAria (BD), FACSDiVa (BD), or Influx Cell Sorter (Cytopeia,
Seattle, WA). LSK, CLP, CMP, GMP,MEP, erythroid, andmegakaryocytic cells
were quantified with a FACSAria or Influx Cell Sorter. Details of the isolation
and staining procedures are given in the Supplemental Experimental
Procedures.
OP9 Cocultures of Lin–CD127+CD117loSca1lo Cells
CLPs were sorted directly onto 2,000 OP9 cells per well in 96-well plates and
cultured in the presence of 10 ng/ml human IL-7 (STEMCELL Technologies)
and human FLT3L (Immunex Corp., Seattle, WA) at 37C in a humidified
chamber and 5%CO2 for 9–12 dayswhen the cells present were then analyzed
by FACS. Wells containing at least 50 PICD19+ cells were scored as positive.
Frequencies of B-lineage-producing CLPs were calculated by ELDA (Hu and
Smyth, 2009).
Transcript Analysis
RNA was extracted with a PicoPure kit (Arcturus Bioscience, Mountain View,
CA) and then cDNA generated with the SuperScript III First-Strand Synthesis
System for RT-PCR (Invitrogen, Burlington, ON). Quantitative real-time PCR
analyses were performed with Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA). The primers are listed in the Supplemental
Experimental Procedures.
Statistical Analysis
GraphPad Prism version 5 was used to perform all basic statistical analyses
including mean ± SEM, CV, and Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
doi:10.1016/j.stem.2012.02.007.
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